{"id":"https://openalex.org/W1807896595","doi":null,"title":"Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.","display_name":"Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.","publication_year":1989,"publication_date":"1989-05-01","ids":{"openalex":"https://openalex.org/W1807896595","mag":"1807896595","pmid":"https://pubmed.ncbi.nlm.nih.gov/2655671"},"language":"en","primary_location":{"id":"pmid:2655671","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2655671","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of mental retardation : AJMR","raw_type":"Case Reports"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011969305","display_name":"Rowland P. Barrett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]},{"id":"https://openalex.org/I2800634083","display_name":"Bradley Hospital","ror":"https://ror.org/02mx8nz45","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800634083","https://openalex.org/I4210151747"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R P Barrett","raw_affiliation_strings":["Brown University Program in Medicine, Emma Pendleton Bradley Hospital, Providence, RI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Brown University Program in Medicine, Emma Pendleton Bradley Hospital, Providence, RI","institution_ids":["https://openalex.org/I27804330","https://openalex.org/I2800634083"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064156692","display_name":"Carl Feinstein","orcid":"https://orcid.org/0000-0003-1213-5749","observed_orcids":["https://orcid.org/0000-0003-1213-5749"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Feinstein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062882268","display_name":"William T. Hole","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W T Hole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":17.1303,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.99254658,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"93","issue":"6","first_page":"644","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10826","display_name":"Behavioral and Psychological Studies","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/3204","display_name":"Developmental and Educational Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10376","display_name":"Suicide and Self-Harm Studies","score":0.10450000315904617,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10106","display_name":"Autism Spectrum Disorder Research","score":0.026399999856948853,"subfield":{"id":"https://openalex.org/subfields/2805","display_name":"Cognitive Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/self-harm","display_name":"self-harm","score":0.8169999718666077},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.9739999771118164},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":1.0},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.859000027179718},{"id":"https://openalex.org/keywords/autism-spectrum-disorder","display_name":"autism spectrum disorder","score":0.9279999732971191},{"id":"https://openalex.org/keywords/intellectual-disability","display_name":"intellectual disability","score":0.9940000176429749},{"id":"https://openalex.org/keywords/extinction","display_name":"extinction","score":0.4970000088214874},{"id":"https://openalex.org/keywords/operant-conditioning","display_name":"operant conditioning","score":0.8100000023841858},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.9020000100135803},{"id":"https://openalex.org/keywords/long-term-treatment-outcomes","display_name":"long-term treatment outcomes","score":0.5230000019073486}],"concepts":[{"id":"https://openalex.org/C2777972943","wikidata":"https://www.wikidata.org/wiki/Q409587","display_name":"Naltrexone","level":4,"score":0.9483054280281067},{"id":"https://openalex.org/C3019590667","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonist","level":5,"score":0.6990772485733032},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6738629341125488},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6501302123069763},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.502281904220581},{"id":"https://openalex.org/C2778140631","wikidata":"https://www.wikidata.org/wiki/Q2026938","display_name":"Opiate","level":3,"score":0.4889744520187378},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4703041911125183},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.447317898273468},{"id":"https://openalex.org/C101991246","wikidata":"https://www.wikidata.org/wiki/Q5422078","display_name":"Extinction (optical mineralogy)","level":2,"score":0.44088298082351685},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24810659885406494},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.24223944544792175},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1689479947090149},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.07900887727737427},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C199289684","wikidata":"https://www.wikidata.org/wiki/Q83353","display_name":"Mineralogy","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001321","descriptor_name":"Autistic Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003216","descriptor_name":"Conditioning, Operant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005108","descriptor_name":"Extinction, Psychological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D009271","descriptor_name":"Naltrexone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012055","descriptor_name":"Reinforcement Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012652","descriptor_name":"Self Mutilation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012652","descriptor_name":"Self Mutilation","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:2655671","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2655671","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of mental retardation : AJMR","raw_type":"Case Reports"},{"id":"mag:1807896595","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2655671","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1995560631","https://openalex.org/W2045098980","https://openalex.org/W2031087264","https://openalex.org/W2093089608","https://openalex.org/W1976866864","https://openalex.org/W345987132","https://openalex.org/W2085568979","https://openalex.org/W2168967262","https://openalex.org/W1491065182","https://openalex.org/W1964801928"],"abstract_inverted_index":{"The":[0,78],"effects":[1,38],"of":[2,14,39,51,70,90,98,106,114],"naloxone":[3,61],"hydrochloride":[4,8],"(Narcan)":[5],"and":[6,18,29,93],"naltrexone":[7,118],"(Trexan)":[9],"on":[10],"the":[11,37,52,60,83,94,112,121],"pervasive":[12],"self-injury":[13,57,71,107],"a":[15,64,124],"12-year-old":[16],"autistic":[17],"mentally":[19],"retarded":[20],"girl":[21],"were":[22],"examined.":[23],"Using":[24],"separate":[25],"multiple":[26],"schedule":[27],"(A1/B/B')":[28],"withdrawal":[30],"(A-B-A1B-A1)":[31],"single-subject":[32],"experimental":[33],"designs,":[34],"we":[35],"investigated":[36],"both":[40],"opiate":[41],"antagonists":[42],"in":[43,88],"serial":[44],"fashion":[45],"under":[46],"double-blind,":[47],"placebo-controlled":[48],"conditions.":[49],"Results":[50],"two":[53,84],"studies":[54],"showed":[55],"that":[56,120],"increased":[58],"during":[59],"trial,":[62],"whereas":[63],"decrease":[65],"to":[66],"near":[67,103],"zero":[68,104],"rates":[69,105],"was":[72,86],"observed":[73],"following":[74,111],"treatment":[75,116],"with":[76,117],"naltrexone.":[77],"differential":[79],"effect":[80],"produced":[81,123],"by":[82],"drugs":[85],"discussed":[87],"terms":[89],"drug":[91],"half-life":[92],"operant":[95],"conditioning":[96],"theory":[97],"extinction.":[99],"Follow-up":[100],"data":[101],"showing":[102],"for":[108],"22":[109],"months":[110],"conclusion":[113],"active":[115],"indicated":[119],"intervention":[122],"durable":[125],"result.":[126]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}